Update on Hodgkin Lymphoma. Since 2014.
Posted on 2014-08-28Guest Editor: Andrea Gallamini
CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
![](/templates/images/icons/pdf_p.png)
e2015015
PATHOBIOLOGY OF HODGKIN LYMPHOMA
![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014040
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014039
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014048
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014053
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014035
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014063
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2014050
CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA
![](/templates/images/icons/pdf_p.png)
![](/templates/images/icons/html_p.png)
e2015015